1 |
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
|
|
|
|
In: New England Journal of Medicine, vol. 367, no. 23, pp. 2204-2213 (2012)
|
|
BASE
|
|
Show details
|
|
2 |
40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004.
|
|
|
|
BASE
|
|
Show details
|
|
|
|